The Chemours Company
CC
$11.12
$0.464.32%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.87% | -7.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.87% | -7.13% | |||
| Cost of Revenue | 0.98% | -7.74% | |||
| Gross Profit | -13.55% | -4.55% | |||
| SG&A Expenses | -39.20% | 82.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.90% | -0.52% | |||
| Operating Income | 83.33% | -67.57% | |||
| Income Before Tax | -100.00% | 130.00% | |||
| Income Tax Expenses | -76.47% | 666.67% | |||
| Earnings from Continuing Operations | 50.00% | 70.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 50.00% | 70.37% | |||
| EBIT | 83.33% | -67.57% | |||
| EBITDA | 30.95% | -44.25% | |||
| EPS Basic | 50.00% | 70.40% | |||
| Normalized Basic EPS | 499.40% | -108.42% | |||
| EPS Diluted | 49.75% | 66.91% | |||
| Normalized Diluted EPS | 499.40% | -108.42% | |||
| Average Basic Shares Outstanding | 0.06% | 0.09% | |||
| Average Diluted Shares Outstanding | 0.06% | 0.09% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -1.06% | -2.20% | |||